Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-051950
Filing Date
2025-05-22
Accepted
2025-05-22 15:23:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9147
  Complete submission text file 0001104659-25-051950.txt   11304
Mailing Address
Business Address TWO LEDGEMONT CENTER 95 HAYDEN AVE LEXINGTON MA 02420 6174029000
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ (Filed by) CIK: 0000042872 (see all company filings)

EIN.: 133461988 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13D/A
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91701 | Film No.: 25976716
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)